Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology?
Pascal Steullet, Jan-Harry Cabungcal, Aline Monin, et al.
Schizophrenia Research (2014) Vol. 176, Iss. 1, pp. 41-51
Open Access | Times Cited: 234

Showing 1-25 of 234 citing articles:

Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression
Anthony A. Grace
Nature reviews. Neuroscience (2016) Vol. 17, Iss. 8, pp. 524-532
Open Access | Times Cited: 971
Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia
Pascal Steullet, J-H Cabungcal, Joseph T. Coyle, et al.
Molecular Psychiatry (2017) Vol. 22, Iss. 7, pp. 936-943
Open Access | Times Cited: 313
The blood–brain barrier in psychosis
Thomas A. Pollak, Svetlana Drndarski, James Stone, et al.
The Lancet Psychiatry (2017) Vol. 5, Iss. 1, pp. 79-92
Closed Access | Times Cited: 259
New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis
Albert C. Yang, Shih‐Jen Tsai
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 8, pp. 1689-1689
Open Access | Times Cited: 248
Vitamin D cell signalling in health and disease
Michael J. Berridge
Biochemical and Biophysical Research Communications (2015) Vol. 460, Iss. 1, pp. 53-71
Closed Access | Times Cited: 192
Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia
Tina Notter, Jennifer M. Coughlin, Tilo Gschwind, et al.
Molecular Psychiatry (2017) Vol. 23, Iss. 2, pp. 323-334
Open Access | Times Cited: 181
Oxidative Stress‐Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives
Evgeny A. Ermakov, E. Dmitrieva, D. Parshukova, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 169
Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder
Thomas A. Lanz, Veronica Reinhart, Mark Sheehan, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 152
Neuroinflammation in Schizophrenia: The Key Role of the WNT/β-Catenin Pathway
Alexandre Vallée
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2810-2810
Open Access | Times Cited: 87
Flavonoids and their role in oxidative stress, inflammation, and human diseases
Klaudia Jomová, Suliman Yousef Alomar, Richard Valko, et al.
Chemico-Biological Interactions (2025), pp. 111489-111489
Open Access | Times Cited: 3
Inflammation in schizophrenia: A question of balance
Juan C. Leza, Borja García‐Bueno, Miquel Bioque, et al.
Neuroscience & Biobehavioral Reviews (2015) Vol. 55, pp. 612-626
Closed Access | Times Cited: 170
Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia
Dorien A. Maas, Astrid Vallès, Gerard J.M. Martens
Translational Psychiatry (2017) Vol. 7, Iss. 7, pp. e1171-e1171
Open Access | Times Cited: 156
Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders
Yeni Kim, Krishna C. Vadodaria, Zsolt Lenkei, et al.
Antioxidants and Redox Signaling (2018) Vol. 31, Iss. 4, pp. 275-317
Open Access | Times Cited: 156
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
Alline C. Campos, Manoela V. Fogaça, Franciele Franco Scarante, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 155
Clozapine as a Model for Antipsychotic Development
Frederick C. Nucifora, Marina Mihaljević, Brian J. Lee, et al.
Neurotherapeutics (2017) Vol. 14, Iss. 3, pp. 750-761
Open Access | Times Cited: 155
Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia
Kim Q., Michel Cuénod, Takao K. Hensch
Schizophrenia Bulletin (2015) Vol. 41, Iss. 4, pp. 835-846
Open Access | Times Cited: 152
Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk
Henry Barron, Sina Hafizi, Ana C. Andreazza, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 3, pp. 651-651
Open Access | Times Cited: 152
N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis
Philippe Conus, Larry J. Seidman, Margot Fournier, et al.
Schizophrenia Bulletin (2017) Vol. 44, Iss. 2, pp. 317-327
Open Access | Times Cited: 140
Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry
Tina Notter, Jennifer M. Coughlin, Akira Sawa, et al.
Molecular Psychiatry (2017) Vol. 23, Iss. 1, pp. 36-47
Closed Access | Times Cited: 136
Early interventions in risk groups for schizophrenia: what are we waiting for?
Iris E. Sommer, Carrie E. Bearden, Edwin van Dellen, et al.
Schizophrenia (2016) Vol. 2, Iss. 1
Open Access | Times Cited: 131
White Matter Disruptions in Schizophrenia Are Spatially Widespread and Topologically Converge on Brain Network Hubs
Paul Klauser, Simon Baker, Vanessa Cropley, et al.
Schizophrenia Bulletin (2016), pp. sbw100-sbw100
Open Access | Times Cited: 118
NMDA Receptor Function During Senescence: Implication on Cognitive Performance
Ashok Kumar
Frontiers in Neuroscience (2015) Vol. 9
Open Access | Times Cited: 114
In Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric Disorders
Harry Pantazopoulos, Sabina Berretta
Neural Plasticity (2015) Vol. 2016, pp. 1-23
Open Access | Times Cited: 110
Childhood sexual and physical abuse: age at exposure modulates impact on functional outcome in early psychosis patients
Luis Alameda, Carlotta Ferrari, Philipp Baumann, et al.
Psychological Medicine (2015) Vol. 45, Iss. 13, pp. 2727-2736
Open Access | Times Cited: 105
Prenatal exposure to environmental insults and enhanced risk of developing Schizophrenia and Autism Spectrum Disorder: focus on biological pathways and epigenetic mechanisms
Nadia Cattane, Juliet Richetto, Annamaria Cattaneo
Neuroscience & Biobehavioral Reviews (2018) Vol. 117, pp. 253-278
Open Access | Times Cited: 105
Page 1 - Next Page

Scroll to top